Formulation and evaluation of gliclazide loaded controlled release microspheres by Dey, Sanjay et al.
1761ISSN 0326-2383
KEY WORDS: Eudragit, Quasi emulsion solvent diffusion, Hypoglycemia.
* Author to whom correspondence should be addressed. E-mail: pharmadu10@gmail.com
Latin American Journal of Pharmacy
(formerly Acta Farmacéutica Bonaerense)
Lat. Am. J. Pharm. 30 (9): 1761-6 (2011)
Regular Article
Received: July 9, 2011
Revised version: September 19, 2011
Accepted: September 19, 2011
Formulation and Evaluation of Gliclazide
Loaded Controlled Release Microspheres
Sanjay DEY, Bibhash C. MOHANTA, Sandipan DAS GUPTA, & Bhaskar MAZUMDER*
Department of Pharmaceutical Sciences, Dibrugarh University,
Dibrugarh, Assam-786004, India
SUMMARY. The aim of this study was to formulate gliclazide loaded controlled release microspheres. Mi-
crospheres were prepared by quasi emulsion solvent diffusion technique using eudragit RLPO, eudragit
RSPO and with their various combinations. The effect of different formulation variables (drug-polymer
ratio and polymer-polymer ratio) on percent yield, mean particle size, encapsulation efficiency and in vitro
release of drug were evaluated. In vivo test of the optimized formulation was performed on streptozotocin
induced type-2 diabetic rat model. The formulated microspheres showed higher encapsulation efficiencies
within the range of 72-84 %. Mean particle size, encapsulation efficiency and in vitro release were found to
be affected by changing in formulation variables. In vitro release study revealed the gliclazide release from
the microspheres was extended for more than 12 h. In vivo hypoglycemic effect of microspheres was more
than 25 h suggesting microspheres are a valuable system for sustained delivery of gliclazide.
